Pre-Clinical Imaging Market worth $797 Million by 2019 - New Report by MarketsandMarkets

Share Article

Over the past three years, the company adopted new product development and launches, and geographical expansions as its key business strategies to ensure its dominance in pre-clinical imaging market: http://www.marketsandmarkets.com/Market-Reports/pre-clinical-molecular-imaging-market-841.html

MarketsandMarkets

MarketsandMarkets

Key Players are Aspect Imaging (Israel), Biospace Lab S.A. (France), Bruker Corporation (U.S.), LI-COR Biosciences (U.S.), Mediso Ltd. (Hungary), MILabs B.V. (Netherlands), MR Solutions Ltd (U.K.), PerkinElmer, Inc. (U.S.)

Advancements in molecular imaging technologies, growing acceptance of preclinical imaging as a legitimate drug development tool and increasing demand for multi-modality imaging technologies in pre-clinical research are key factors fuelling the growth of the pre-clinical imaging market.

This report studies the global pre-clinical imaging market over the forecast period of 2014 to 2019. The market is expected to reach ~$797 million by 2019, at CAGR of 6.0% from 2014 to 2019.

Get Full Report @ http://www.marketsandmarkets.com/Market-Reports/pre-clinical-molecular-imaging-market-841.html

Based on modality the global preclinical imaging market is divided into seven major segments, namely, optical imaging, nuclear imaging, micro-MRI, micro-CT, micro-ultrasound, photoacoustic and magnetic particle imaging systems. The preclinical optical imaging systems market includes bioluminescence/fluorescence imaging systems, standalone fluorescence imaging systems, optical + X-ray/optical + CT imaging systems. The preclinical nuclear imaging systems market comprises micro-PET systems (standalone PET, PET/CT, and PET/MRI), micro-SPECT systems (standalone SPECT, SPECT/CT, and SPECT/MRI) and trimodality (PET/SPECT/CT) imaging systems.

Bases on the reagents the global preclinical imaging market is divided into five segments namely, optical imaging reagents, nuclear imaging reagents, MRI contrast agents, ultrasound contrast agents, and CT contrast agents. The optical imaging reagents market is further subsegmented as bioluminescent and fluorescent imaging reagents. Likewise the nuclear imaging reagents market is divided as preclinical PET tracers and SPECT probes.

For More Details @ http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=841

A number of factors such as technological developments in molecular imaging technologies such as PET and MRI, rising acceptance of preclinical imaging as a legitimate drug development tool and increasing number of preclinical research activities are propelling the growth of the global pre-clinical imaging market. However high cost of imaging systems, reduced NIH (National Institutes of Health) funding for life science research activities and high cost and data requirements for bringing new imaging technology are some of the major factors restraining the growth of this market. In addition to this challenges associated with the application of radioisotopes such as short half- life of PET radioisotopes and high cost involved in the generation of these isotopes limits the demand for micro-PET systems especially in developing countries where budget scarcity is a major issue with life science researchers.

For Report Inquiry Speak with Research Analyst @ http://www.marketsandmarkets.com/speaktoanalyst.asp?id=841

On the basis of geography, this market is classified into four regions, namely North America, Europe, Asia-Pacific and Rest of the World. In 2014 the global pre-clinical imaging market is estimated to be dominated by North America. A number of factors such as the high volume of pre-clinical research studies, technological advancements, and well-established infrastructure to conduct pre-clinical research are driving the growth of the pre-clinical imaging market in the North American region. The Asia-Pacific market is expected to grow at the highest CAGR from 2014 to 2019. This is primarily due to the factors such as rising number of CROs offering pre-clinical research studies and increasing outsourcing of preclinical research by global pharma companies to developing Asian countries. Furthermore rising government investment to develop pharmaceutical R&D in emerging nations is also intensifying the number of preclinical research studies in this region.

New product launches is the key growth strategy adopted by the major players to develop their position in the global pre-clinical imaging systems and reagents market. Moreover strategies such as partnerships, agreements, collaborations, expansions and acquisitions were also adopted by a significant number of market players to strengthen their product portfolio and expand their geographic presence in the pre-clinical imaging market.

Browse related reports
Diagnostic Imaging Market by X-ray Systems (Digital, Analog, Portable), Computed Tomography, Ultrasound Imaging Systems (2D, 3D, 4D, Doppler), MRI Machines (Closed & Open), and Nuclear Imaging Systems (SPECT, PET, PET/CT) - Global Forecasts to 2018
http://www.marketsandmarkets.com/Market-Reports/diagnostic-imaging-market-411.html

Advances in Magnetic Resonance Imaging (MRI) Market (2013-2018) - Technology Trend Analysis – By Architecture, Field Strengths, Technology & Applications in Medical Diagnostics with Market Landscape Analysis – Estimates up to 2018
http://www.marketsandmarkets.com/Market-Reports/MRI-advanced-technologies-and-global-market-99.html

About MarketsandMarkets
MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit MarketsandMarkets Blog @http://mnmblog.org/market-research/healthcare/medical-devices

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Mr.Rohan
@marketsmarkets
since: 04/2009
Follow >
Market Research Report
since: 12/2010
Like >
Follow us on
Visit website